Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies

Sabrina Salani, Chiara Donadoni, Federica Rizzo, Nereo Bresolin, Giacomo P. Comi, Stefania Corti

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Introduction • Transdifferentiation of somatic cells in skeletal myoblasts • Myogenic cell induction from ESCs - The first method: generation of MMPs from ESCs and their differentiation into myogenic cells - Isolation of MMPs - Differentiation into skeletal myoblasts - The second method: EB generation and differentiation into skeletal muscle - Formation of EBs - Differentiation of EBs into skeletal myoblasts • Protocols for myogenic cell induction from iPSCs • Mouse and human-pluripotent derived myocytes as an in vitro model of MDs • Therapeutic development based on ESC- or iPSC-derived cells • Conclusion Muscular dystrophies (MDs) are a heterogeneous group of inherited disorders characterized by progressive muscle wasting and weakness likely associated with exhaustion of muscle regeneration potential. At present, no cures or efficacious treatments are available for these diseases, but cell transplantation could be a potential therapeutic strategy. Transplantation of myoblasts using satellite cells or other myogenic cell populations has been attempted to promote muscle regeneration, based on the hypothesis that the donor cells repopulate the muscle and contribute to its regeneration. Embryonic stem cells (ESCs) and more recently induced pluripotent stem cells (iPSCs) could generate an unlimited source of differentiated cell types, including myogenic cells. Here we review the literature regarding the generation of myogenic cells considering the main techniques employed to date to elicit efficient differentiation of human and murine ESCs or iPSCs into skeletal muscle. We also critically analyse the possibility of using these cellular populations as an alternative source of myogenic cells for cell therapy of MDs.

Original languageEnglish
Pages (from-to)1353-1364
Number of pages12
JournalJournal of Cellular and Molecular Medicine
Volume16
Issue number7
DOIs
Publication statusPublished - Jul 2012

Fingerprint

Induced Pluripotent Stem Cells
Muscular Dystrophies
Muscle Cells
Skeletal Muscle
Skeletal Myoblasts
Embryonic Stem Cells
Regeneration
Therapeutics
Matrix Metalloproteinases
Cell Transdifferentiation
In Vitro Techniques
Muscles
Cell Separation
Myoblasts
Cell Transplantation
Muscle Weakness
Cell- and Tissue-Based Therapy
Population
Cell Differentiation
Transplantation

Keywords

  • Embryonic stem cell
  • Induced pluripotent stem cell
  • Muscular dystrophy
  • Myoblast
  • Protocol

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Medicine

Cite this

@article{074c5bfe8ce8480f9cfa6bdde78beb95,
title = "Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies",
abstract = "Introduction • Transdifferentiation of somatic cells in skeletal myoblasts • Myogenic cell induction from ESCs - The first method: generation of MMPs from ESCs and their differentiation into myogenic cells - Isolation of MMPs - Differentiation into skeletal myoblasts - The second method: EB generation and differentiation into skeletal muscle - Formation of EBs - Differentiation of EBs into skeletal myoblasts • Protocols for myogenic cell induction from iPSCs • Mouse and human-pluripotent derived myocytes as an in vitro model of MDs • Therapeutic development based on ESC- or iPSC-derived cells • Conclusion Muscular dystrophies (MDs) are a heterogeneous group of inherited disorders characterized by progressive muscle wasting and weakness likely associated with exhaustion of muscle regeneration potential. At present, no cures or efficacious treatments are available for these diseases, but cell transplantation could be a potential therapeutic strategy. Transplantation of myoblasts using satellite cells or other myogenic cell populations has been attempted to promote muscle regeneration, based on the hypothesis that the donor cells repopulate the muscle and contribute to its regeneration. Embryonic stem cells (ESCs) and more recently induced pluripotent stem cells (iPSCs) could generate an unlimited source of differentiated cell types, including myogenic cells. Here we review the literature regarding the generation of myogenic cells considering the main techniques employed to date to elicit efficient differentiation of human and murine ESCs or iPSCs into skeletal muscle. We also critically analyse the possibility of using these cellular populations as an alternative source of myogenic cells for cell therapy of MDs.",
keywords = "Embryonic stem cell, Induced pluripotent stem cell, Muscular dystrophy, Myoblast, Protocol",
author = "Sabrina Salani and Chiara Donadoni and Federica Rizzo and Nereo Bresolin and Comi, {Giacomo P.} and Stefania Corti",
year = "2012",
month = "7",
doi = "10.1111/j.1582-4934.2011.01498.x",
language = "English",
volume = "16",
pages = "1353--1364",
journal = "Journal of Cellular and Molecular Medicine",
issn = "1582-1838",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies

AU - Salani, Sabrina

AU - Donadoni, Chiara

AU - Rizzo, Federica

AU - Bresolin, Nereo

AU - Comi, Giacomo P.

AU - Corti, Stefania

PY - 2012/7

Y1 - 2012/7

N2 - Introduction • Transdifferentiation of somatic cells in skeletal myoblasts • Myogenic cell induction from ESCs - The first method: generation of MMPs from ESCs and their differentiation into myogenic cells - Isolation of MMPs - Differentiation into skeletal myoblasts - The second method: EB generation and differentiation into skeletal muscle - Formation of EBs - Differentiation of EBs into skeletal myoblasts • Protocols for myogenic cell induction from iPSCs • Mouse and human-pluripotent derived myocytes as an in vitro model of MDs • Therapeutic development based on ESC- or iPSC-derived cells • Conclusion Muscular dystrophies (MDs) are a heterogeneous group of inherited disorders characterized by progressive muscle wasting and weakness likely associated with exhaustion of muscle regeneration potential. At present, no cures or efficacious treatments are available for these diseases, but cell transplantation could be a potential therapeutic strategy. Transplantation of myoblasts using satellite cells or other myogenic cell populations has been attempted to promote muscle regeneration, based on the hypothesis that the donor cells repopulate the muscle and contribute to its regeneration. Embryonic stem cells (ESCs) and more recently induced pluripotent stem cells (iPSCs) could generate an unlimited source of differentiated cell types, including myogenic cells. Here we review the literature regarding the generation of myogenic cells considering the main techniques employed to date to elicit efficient differentiation of human and murine ESCs or iPSCs into skeletal muscle. We also critically analyse the possibility of using these cellular populations as an alternative source of myogenic cells for cell therapy of MDs.

AB - Introduction • Transdifferentiation of somatic cells in skeletal myoblasts • Myogenic cell induction from ESCs - The first method: generation of MMPs from ESCs and their differentiation into myogenic cells - Isolation of MMPs - Differentiation into skeletal myoblasts - The second method: EB generation and differentiation into skeletal muscle - Formation of EBs - Differentiation of EBs into skeletal myoblasts • Protocols for myogenic cell induction from iPSCs • Mouse and human-pluripotent derived myocytes as an in vitro model of MDs • Therapeutic development based on ESC- or iPSC-derived cells • Conclusion Muscular dystrophies (MDs) are a heterogeneous group of inherited disorders characterized by progressive muscle wasting and weakness likely associated with exhaustion of muscle regeneration potential. At present, no cures or efficacious treatments are available for these diseases, but cell transplantation could be a potential therapeutic strategy. Transplantation of myoblasts using satellite cells or other myogenic cell populations has been attempted to promote muscle regeneration, based on the hypothesis that the donor cells repopulate the muscle and contribute to its regeneration. Embryonic stem cells (ESCs) and more recently induced pluripotent stem cells (iPSCs) could generate an unlimited source of differentiated cell types, including myogenic cells. Here we review the literature regarding the generation of myogenic cells considering the main techniques employed to date to elicit efficient differentiation of human and murine ESCs or iPSCs into skeletal muscle. We also critically analyse the possibility of using these cellular populations as an alternative source of myogenic cells for cell therapy of MDs.

KW - Embryonic stem cell

KW - Induced pluripotent stem cell

KW - Muscular dystrophy

KW - Myoblast

KW - Protocol

UR - http://www.scopus.com/inward/record.url?scp=84863089743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863089743&partnerID=8YFLogxK

U2 - 10.1111/j.1582-4934.2011.01498.x

DO - 10.1111/j.1582-4934.2011.01498.x

M3 - Article

C2 - 22129481

AN - SCOPUS:84863089743

VL - 16

SP - 1353

EP - 1364

JO - Journal of Cellular and Molecular Medicine

JF - Journal of Cellular and Molecular Medicine

SN - 1582-1838

IS - 7

ER -